Offering Pharmaceutical Samples: The Role of Physician Learning and Patient Payment Ability

References

• Arnst C. The waning of the blockbuster drug. Business Week (2004) October 17). http://businessweek.com/stories/2004-10-17/the-waning-of-the-blockbuster-drugGoogle Scholar
• Coscelli A, Shum M. An empirical model of learning and patient spillovers in new drug entry. J. Econometrics (2004) 122(2):213–246Crossref, Google Scholar
• Crawford GS, Shum M. Uncertainty and learning in pharmaceutical demand. Econometrica (2005) 73(4):1137–1173Crossref, Google Scholar
• Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DJ. Characteristics of recipients of free prescription drug samples: A nationally representative analysis. Amer. J. Public Health (2008) 98(2):284–289Crossref, Google Scholar
• Gönül F, Carter F, Petrova E, Srinivasan K. Promotion of prescription drugs and its impact on physicians' choice behavior. J. Marketing (2001) 65(3):79–90Crossref, Google Scholar
• Joseph K, Mantrala M. A model of the role of free drug samples in physicians' prescription decisions. Marketing Lett. (2009) 20(1):15–29Crossref, Google Scholar
• Lurker N, Caprara B. The sampling subsidy. Pharmaceutical Executive (2005) February 1). http://www.pharmexec.com/pharmexec/PE+Features/The-Sampling-Subsidy/ArticleStandard/Article/detail/146582Google Scholar
• Manchanda P, Rossi PE, Chintagunta PK. Response modeling with nonrandom marketing-mix variables. J. Marketing Res. (2004) 41(4):467–478Crossref, Google Scholar
• Mizik N, Jacobson R. Are physicians “easy marks”? Quantifying the effects of detailing and sampling on new prescriptions. Management Sci. (2004) 50(12):1704–1715Link, Google Scholar
• Narayanan S, Manchanda P, Chintagunta PK. Temporal differences in the role of marketing communication in new product categories. J. Marketing Res. (2005) 42(3):278–290Crossref, Google Scholar
• Wosinska M. Direct-to-consumer advertising and drug therapy compliance. J. Marketing Res. (2005) 42(3):323–332Crossref, Google Scholar